骶髂關節疾病治療市場規模、佔有率和成長分析：按治療方法、診斷方法、最終用戶和地區分類－2026-2033年產業預測

2024 年全球骶髂關節發炎治療市場價值為 4.5 億美元，預計到 2025 年將成長至 4.815 億美元，到 2033 年將成長至 9 億美元，在預測期（2026-2033 年）內複合年成長率為 7.0%。

全球骶髂關節炎治療市場的成長主要得益於標靶細胞激素路徑生物製藥療法的進步。臨床醫生擴大利用生物標記數據進行個人化治療，透過為每位患者選擇合適的有效藥物（例如塞替尼單抗），加速症狀緩解並降低手術率。為了因應這一成功，製藥公司正積極投資於創新在研藥物，而保險公司則透過實施分階段的保險覆蓋計畫來優先考慮已證實有效的療法。因此，醫院正在建立整合風濕病學、放射學和物理治療的多學科診療中心，這不僅創造了新的商機，也提高了患者的治療依從性。總體而言，在全球保險公司接受度不斷提高和合作研究舉措的推動下，該市場預計將以12%的複合年成長率成長。

全球骶髂關節發炎治療市場促進因素

骶髂關節炎治療的全球市場正因臨床醫生對此疾病症狀認知的顯著提高而大大推動，這主要得益於各項專項教育舉措。這種認知的提升促使患者更早接受治療，並提高了他們對各種治療方案的接受度。隨著醫生擴大考慮緩解疾病療法，患者也越來越傾向於尋求專科護理。此外，創新療法的納入也進一步擴大了整體市場需求。合作研究進一步驗證了治療的有效性，增強了臨床醫生的信心，並提高了患者的接受度，最終促進了各地區的永續成長。

全球骶髂關節炎治療市場面臨的限制因素

全球骶髂關節發炎治療市場面臨一項重大挑戰：治療費用高昂。高昂的費用限制了許多醫療系統和患者的就醫途徑，迫使他們因經濟拮据而選擇價格較低的替代方案。這種經濟負擔使得醫療服務提供者不願意推薦昂貴的治療方案，而保險公司也設定了嚴格的報銷標準。因此，患者接受治療的意願受到阻礙，市場擴張速度也隨之放緩。由此，製造商被迫應對價格敏感性，並經常採取折扣策略，但這會降低利潤率並阻礙永續成長。這些價格障礙也阻礙了研發投入，最終限制了創新療法的出現。

全球骶髂關節發炎治療市場趨勢

隨著高解析度肌肉骨骼影像技術的廣泛應用，全球骶髂關節炎治療市場正經歷顯著的變化。高解析度肌肉骨骼成像技術的進步提高了診斷準確性，使骶髂關節炎的早期發現成為可能，並幫助臨床醫生更準確地判斷疾病階段。此外，磁振造影（MRI）和定量生物標記的日益普及，使得區分發炎性和退化性變化變得更加容易，從而最大限度地減少了侵入性診斷程序的需求。隨著這些影像技術的普及和保險報銷模式的相應調整，醫療機構正將高解析度診斷納入標準診療流程，導致全球對相關影像服務和個人化治療方案的需求不斷成長。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球骶髂關節發炎治療市場規模：依治療類型分類

• 製藥
• 物理治療
• 射頻消融術
• 骶髂關節注射
• 手術固定

全球骶髂關節炎治療市場規模：依診斷方法分類

• 影像檢查
• 身體檢查
• 臨床試驗

全球骶髂關節發炎治療市場規模：以最終用戶分類

• 醫院
• 整形外科診所
• 風濕病診所

全球骶髂關節發炎治療市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Haemonetics Corporation
• Wright Medical Group NV
• Bio Techne Corporation
• Zyga Technology Inc
• NuTech Medical Inc
• CoorsTek Medical LLC
• Medacta International SA
• Aspen Medical Products LLC
• Cooper Companies Inc
• DePuy Synthes Companies
• Xtant Medical Holdings Inc
• Camber Spine Technologies LLC
• CariCarba Spine Corporation
• Inspire Medical Systems Inc
• RTI Surgical Holdings Inc
• Wright Medical Group NV
• Fresenius Medical Care AG
• NView Medical Inc
• Convatec Group plc
• Vertos Medical Inc

結論與建議

Global Sacroiliitis Treatment Market size was valued at USD 450.0 Million in 2024 and is poised to grow from USD 481.5 Million in 2025 to USD 900.0 Million by 2033, growing at a CAGR of 7.0% during the forecast period (2026-2033).

The growth of the global sacroiliitis treatment market is primarily fueled by advances in biologic therapies targeting cytokine pathways. Clinicians are increasingly utilizing biomarker data to personalize treatment, matching patients with effective agents like secukinumab, which enhances symptom relief and reduces surgery rates. This success motivates pharmaceutical companies to invest in innovative pipeline candidates, while insurance providers are adapting by offering tiered coverage that prioritizes proven therapies. As a result, hospitals are establishing multidisciplinary clinics that integrate rheumatology, radiology, and physical therapy, thus creating new revenue opportunities and improving patient adherence. Overall, the market is expected to experience a compound annual growth rate of 12 percent, bolstered by wider payer acceptance and collaborative research initiatives across the globe.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Sacroiliitis Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Sacroiliitis Treatment Market Segments Analysis

Global sacroiliitis treatment market is segmented by treatment type, diagnosis method, end user and region. Based on treatment type, the market is segmented into Medications, Physical Therapy, Radiofrequency Ablation, Sacroiliac Joint Injections and Surgical Fusion. Based on diagnosis method, the market is segmented into Imaging Studies, Physical Examination and Laboratory Tests. Based on end user, the market is segmented into Hospitals, Orthopedic Clinics and Rheumatology Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Sacroiliitis Treatment Market

The global market for sacroiliitis treatment is being significantly bolstered by an increase in clinician awareness regarding the symptoms of this condition, driven by dedicated educational initiatives. This enhanced knowledge leads to earlier patient referrals and a greater acceptance of diverse therapeutic options. As physicians become more inclined to consider disease-modifying treatments, patients are also more likely to seek specialized care. Additionally, the incorporation of innovative treatment modalities into standard practices is widening overall market demand. Collaborative research efforts further support treatment validation, reinforcing clinician confidence and encouraging patient acceptance, ultimately contributing to sustained growth across various regions.

Restraints in the Global Sacroiliitis Treatment Market

The Global Sacroiliitis Treatment market faces significant challenges due to the high costs associated with treatment, which restrict access for numerous healthcare systems and patients operating under financial constraints that favor cheaper alternatives. This economic burden discourages healthcare providers from recommending high-end therapies and leads payers to enforce strict reimbursement criteria, ultimately hindering patient adoption and slowing market expansion. As a result, manufacturers are compelled to address price sensitivity, frequently implementing discount strategies that may diminish profit margins and hinder sustainable growth. These pricing obstacles also impede investment in research and development, thereby limiting the emergence of innovative treatment options.

Market Trends of the Global Sacroiliitis Treatment Market

The Global Sacroiliitis Treatment market is undergoing significant transformation shaped by the rising adoption of precision imaging technologies. High-resolution musculoskeletal imaging advancements are enhancing diagnostic accuracy and enabling earlier detection of sacroiliitis, allowing clinicians to better stage the disease. Increasingly, magnetic resonance imaging techniques and the use of quantitative biomarkers are facilitating the differentiation between inflammatory and degenerative changes, minimizing the need for invasive diagnostic procedures. As these imaging technologies become more prevalent and reimbursement models adapt to support them, healthcare providers are integrating precision diagnostics in standard practices, consequently driving the demand for related imaging services and tailored therapeutic strategies worldwide.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Sacroiliitis Treatment Market Size by Treatment Type & CAGR (2026-2033)

• Market Overview
• Medications
• Physical Therapy
• Radiofrequency Ablation
• Sacroiliac Joint Injections
• Surgical Fusion

Global Sacroiliitis Treatment Market Size by Diagnosis Method & CAGR (2026-2033)

• Market Overview
• Imaging Studies
• Physical Examination
• Laboratory Tests

Global Sacroiliitis Treatment Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Orthopedic Clinics
• Rheumatology Clinics

Global Sacroiliitis Treatment Market Size & CAGR (2026-2033)

• North America (Treatment Type, Diagnosis Method, End User)
  • US
  • Canada
• Europe (Treatment Type, Diagnosis Method, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Treatment Type, Diagnosis Method, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Treatment Type, Diagnosis Method, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Treatment Type, Diagnosis Method, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Haemonetics Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wright Medical Group NV
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio Techne Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zyga Technology Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NuTech Medical Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CoorsTek Medical LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medacta International SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aspen Medical Products LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cooper Companies Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DePuy Synthes Companies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Xtant Medical Holdings Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Camber Spine Technologies LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CariCarba Spine Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inspire Medical Systems Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RTI Surgical Holdings Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wright Medical Group NV
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Medical Care AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NView Medical Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Convatec Group plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vertos Medical Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations